Cargando…
Molecular Investigation of SARS–CoV-2 Proteins and Their Interactions with Antiviral Drugs
A new Coronavirus strain, named SARS-CoV-2, suddenly emerged in early December 2019. SARS-CoV-2 resulted in being dramatically infectious, with thousands of people infected. In this scenario, and without effective vaccines available, the importance of an immediate tool to support patients and agains...
Autores principales: | Calligari, Paolo, Bobone, Sara, Ricci, Giorgio, Bocedi, Alessio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7232184/ https://www.ncbi.nlm.nih.gov/pubmed/32295237 http://dx.doi.org/10.3390/v12040445 |
Ejemplares similares
-
Investigating the potential antiviral activity drugs against SARS-CoV-2 by molecular docking simulation
por: El-hoshoudy, A.N.
Publicado: (2020) -
SARS-CoV-2: An Update on Potential Antivirals in Light of SARS-CoV Antiviral Drug Discoveries
por: Elshabrawy, Hatem A.
Publicado: (2020) -
SARS‐CoV‐2–host proteome interactions for antiviral drug discovery
por: Liu, Xiaonan, et al.
Publicado: (2021) -
Antiviral drugs against SARS-CoV-2
por: Aiello, Tommaso Francesco, et al.
Publicado: (2022) -
The
Interaction of Hypericin with SARS-CoV-2
Reveals a Multimodal Antiviral Activity
por: Delcanale, Pietro, et al.
Publicado: (2022)